Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Journal of Experimental Medicine|September 1, 1993
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cellD Billadeau, G Ahmann, P Greipp, et al.The Journal of Rheumatology|October 1, 1986
Chemical classification of hereditary amyloidosis in Brazilian families and identification of gene carriersM D Benson, F E Dwulet, M A Scheinberg, et al.Leukemia & Lymphoma|January 1, 1995
Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cellsN E Kay, M M Oken, R Kyle, et al.Blood|December 1, 1991
Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual diseaseD Billadeau, M Blackstadt, P Greipp, et al.Leukemia & Lymphoma|April 8, 1999
Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487)N Kay, T Leong, R A Kyle, et al.Blood|October 1, 1992
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsD Billadeau, L Quam, W Thomas, et al.Bone Marrow Transplantation|September 14, 1999
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myelomaS Rajkumar, R Fonseca, M Lacy, et al.Blood|October 1, 1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialP Liu, T Leong, L Quam, et al.Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.Pageof 1